Massive Bio

Reporting live from Dallas📍 The Massively Insightful Summit is underway, and it has been an incredible start. Our Co-Founder and Chief Medical AI Officer @DrArturoAI opened with a special video message and the official #NexusPulse announcement. Our Co-Founder and CEO Selin Kurnaz took the stage with a powerful opening, and our Co-Founder, CTO and COO Çağatay Çulcuoğlu led the first panel with conversations that set the bar high. Big day for Massive Bio, and we are not even close to done yet. Stay tuned for more. 👀 #MassivelyInsightful #MassiveBio #NexusPulse #OncologyInnovation

The Massively Insightful Summit may be over. But the Massively Insightful Podcast is just getting started. 🎙️ Panel discussions on clinical trial access, AI in oncology, and the future of cancer care. A patient story segment that grounded it all. And connections that will last well beyond today. Full panel recordings coming soon to our website and YouTube channel. Stay tuned. Thank you to every speaker, moderator, panelist, and guest who made today possible. 🙏 #MassivelyInsightful #MassiveBio #NexusPulse #OncologyInnovation

Massive Bio launches NexusPulse™, the real-time AI signal engine for oncology markets. Always-on analytics. Prioritized signals. Next-best actions. 40%+ reduction in signal-to-action time in early deployments. massivebio.com/massive-bio-la… #NexusPulse #MassiveBio #Oncology #AIinHealthcare

Today's the day. The Massively Insightful Summit is live in Dallas — the kickoff event for an upcoming podcast hosted by Selin Kurnaz. 🚨 We have a big announcement dropping during opening remarks. Stay tuned. Moderators: Selin Kurnaz | Cagatay Culcuoglu | @arifkamalmd | @ChickyPortteus | @jovecastellanos Panelists: @NasimAfsarMD | @therealpanna | @s_sivendran | Neha Londono | James Wang | Sara Rana | Mark Conklin | Mark Fleury Follow along for live updates all day.

✨ Meet the first line of our #MassivelyInsightfulSummit speakers, the live studio kickoff of a brand-new podcast series by our Co-Founder & CEO, Selin Kurnaz, PhD. 🎙️ Nasim Afsar, MD MBA MHM 🎙️ Arif Kamal, MD MBA MHS 🎙️ Panna Sharma 🎙️ Chandini Kumar Portteus, MPH Who do you think is joining them next? 👀 🗓️ Today is the last day to RSVP - secure your spot: share.hsforms.com/2ms37aG4MRpql1…

The New York Stock Exchange is where the world's biggest stories are told. And we got to tell ours. Our Co-Founder & CEO Selin Kurnaz (@skurnaz ) joined Jane King (@MarketJane) on the @NYSE floor for Idea Exchange on @GenWealthTV. This conversation is about where @MassiveBio comes from and the human need that made this company necessary. Cancer touches everyone's lives. We built Massive Bio because patients deserved better options and a smarter path to finding them. That path is now powered by Reticulum Nexus, the world's first fully agentic AI-driven patient journey platform, built to ensure every cancer patient gets access to the right treatment at the right time, with intelligence and precision that was never possible before. The mission was clear from day one. It still is. 🔗 Watch the full interview: massivebio.com/using-ai-to-fi… #NYSE #IdeaExchange #GenwealthTV #ClinicalTrials #Oncology #AIinHealthcare

Join us in Dallas for the launch of Massively Insightful. Request your seat. On March 19 in Dallas, our Co-Founder & CEO, Selin Kurnaz, will host the kickoff of Massively Insightful, a live studio summit bringing together leaders across oncology, AI, pharma, payers, and healthcare innovation. This executive gathering will explore where clinical trials, patient access, capital strategy, and artificial intelligence intersect in real-world execution. Full speaker lineup and program details coming soon. If you would like to request attendance, submit your RSVP here: 1leeg.share.hsforms.com/2ms37aG4MRpql1… As seating is limited, submitting the form allows us to review requests thoughtfully. Confirmed guests will receive a follow-up confirmation. #MassivelyInsightful #OncologyLeadership #AIinHealthcare #ClinicalTrials #HealthcareInnovation #Dallas

Access should never depend on language. We expanded Patient Connect into five additional languages: #German, #BrazilianPortuguese, #Greek, #Romanian and #Hebrew This update allows more patients and families to explore clinical trial options in their native language, with clarity and confidence. Every new language strengthens our local presence while reinforcing our global mission: connecting patients to the right clinical trials, wherever they are. Learn more at network.massivebio.com/sign-in/patien…

Inside the New York Stock Exchange. Our Co-Founder & CEO, Selin Kurnaz, PhD, joins Jane King (@MarketJane), CEO of LilaMax Media and NYSE Host, for a walk-and-talk conversation at the @NYSE , followed by a focused interview on AI, capital markets, and the evolving future of clinical trials. From patient access to global execution, the discussion goes straight to where healthcare innovation meets real-world scale. Full interview coming soon. Stay tuned. #NYSE #AIinHealthcare #ClinicalTrials #HealthTech #CapitalMarkets

Last week, our Account Manager for Spain, Gisela Saladino, represented Massive Bio at the IV International Thoracic Cancer Debates (#ITCD2026) in Las Palmas de Gran Canaria. The meeting brought together experts in thoracic oncology to discuss current research, therapeutic strategies, and key clinical questions in lung cancer through in-depth scientific exchange. Being present at forums like ITCD helps us stay closely connected to clinical practice and ongoing discussions shaping thoracic oncology across regions. #ITCD2026 #ThoracicOncology #Oncology #ClinicalTrials #Spain

KRAS mutation. NSCLC. No prior therapy yet. Some clinical trials are designed for this exact moment. Explore options: massivebio.com/advanced-nsclc… #LungCancer #NSCLC #KRASMutation #ClinicalTrials #CancerSupport

Every cancer journey is different. But no one should face it alone. February 4 is World Cancer Day. And the commitment continues beyond today. Visit Massive Bio: massivebio.com/?utm_source=tw… #WorldCancerDay #February4 #UnitedByUnique

Referral black holes slow oncology down. During the first day of #SCOPE2026, Massive Bio introduces TrialRelay™, turning referrals into accountable, trackable handoffs rather than passive networks. From matching to enrollment orchestration. 🔗 massivebio.com/massive-bio-la…

📖 New publications added to our Publications & Media page! Featuring recent work in Nature / npj Precision Oncology, NEJM AI, AI in Precision Oncology, ASH/Blood, and ongoing Medscape Practical AI commentary. 🔗 massivebio.com/massive-bio-pu… #Oncology #AI #ClinicalTrials #DigitalHealth #PrecisionMedicine

Selin Kurnaz Recognized Among The 100 Most Influential CEOs in Oncology in 2025 @MassiveBio oncodaily.com/community/seli… #OncoDaily #Oncology #Cancer #Health #Medicine #MedX

Living with MDS and ongoing transfusions raises real questions. A clinical study may be available for some people with lower-risk, transfusion-dependent MDS. massivebio.com/myelodysplasti… #MDS #ClinicalTrials

A candid conversation on entrepreneurship, pivots, and building access where it matters. Our Co-Founder & CEO, Selin Kurnaz, PhD, joined @molecule2markt host Raman Sehgal(@ramanelli) for an open discussion on the realities behind @MassiveBio’s journey, from personal motivation to applying AI in clinical trials and patient access. The episode explores fundraising, major pivots, and what it truly takes to build in healthcare when the path is anything but linear. 🎧 Listen here: Apple: lnkd.in/ghFS4ExU Spotify: lnkd.in/dSVcupg Amazon: lnkd.in/dWRBjBbX #Podcast #AIinHealthcare #ClinicalTrials #HealthTech #Leadership

Helping people find clarity around clinical trials takes trust. The Massive Bio Affiliate Program allows you to share a trusted, no-cost resource that helps your loved ones explore clinical trials. massivebio.com/?utm_source=x&… #massivebio #clinicaltrials #cancer #patientsupport

Most people with advanced NSCLC never hear about all their options. If you’re exploring whether clinical trials could be relevant, you can start here: massivebio.com/advanced-nsclc… #NSCLC #ClinicalTrials

As the year ends, we’re reflecting on the conversations, questions, and work that shaped 2025. massivebio.com/?utm_source=x&… #massivebio #clinicaltrials #cancer #patientsupport